Newborn Screening | Infant Care | Health Care | Baby's First Testjohndemello7
Baby's First Test is the nation's newborn screening education center for parents, health professionals, and the public on the newborn screening system.
Visit http://www.babysfirsttest.org/
Dr. Amir Hannan Digital Health Assembly 2015DHA2015
A Partnership Of Trust; Improving Public Health Through Access To Medical Records and Informed Healthcare Incorporating Shared Decision Making
Dr. Amir Hannan
Digital Health Assembly: Open Innovation 2015
Transforming Care: Share and Learn Webinar – 29 March 2018NHS England
Topic One: "The ERIN Initiative"
Guest speakers: Susan Holloway, NHS Chorley & South Ribble CCG and NHS Greater Preston CCG and Sheila Roberts, Lancashire Care NHS Foundation Trust
The aim of "The ERIN (Education, Resources, Interventions and Networking) Initiative" is to provide a local, accessible, responsive, early assessment and intervention service for children aged 0-5 years who may be placed on the pre-school Autism Spectrum Disorder (ASD) pathway.
This webinar reports on the progress made during a pilot which commenced on 1st October 2017 to implement a service which deals with complex/challenging behaviors of children who may or may not go on to have a diagnosis with autism.
Topic Two: An introduction and brief overview of the Source4Networks platform
Session led by Rob Cockburn, Sustainable Improvement Team, NHS England
This topic provides an introduction and brief overview of the Source4Networks platform and its potential to support the Transforming Care Programme.
Newborn Screening | Infant Care | Health Care | Baby's First Testjohndemello7
Baby's First Test is the nation's newborn screening education center for parents, health professionals, and the public on the newborn screening system.
Visit http://www.babysfirsttest.org/
Dr. Amir Hannan Digital Health Assembly 2015DHA2015
A Partnership Of Trust; Improving Public Health Through Access To Medical Records and Informed Healthcare Incorporating Shared Decision Making
Dr. Amir Hannan
Digital Health Assembly: Open Innovation 2015
Transforming Care: Share and Learn Webinar – 29 March 2018NHS England
Topic One: "The ERIN Initiative"
Guest speakers: Susan Holloway, NHS Chorley & South Ribble CCG and NHS Greater Preston CCG and Sheila Roberts, Lancashire Care NHS Foundation Trust
The aim of "The ERIN (Education, Resources, Interventions and Networking) Initiative" is to provide a local, accessible, responsive, early assessment and intervention service for children aged 0-5 years who may be placed on the pre-school Autism Spectrum Disorder (ASD) pathway.
This webinar reports on the progress made during a pilot which commenced on 1st October 2017 to implement a service which deals with complex/challenging behaviors of children who may or may not go on to have a diagnosis with autism.
Topic Two: An introduction and brief overview of the Source4Networks platform
Session led by Rob Cockburn, Sustainable Improvement Team, NHS England
This topic provides an introduction and brief overview of the Source4Networks platform and its potential to support the Transforming Care Programme.
From Birth to Adolescence_ The Journey with Your Pediatrician.pptxAnkura Hospital
A new mother is faced with the dilemma of whether to take her child to visit a family doctor or the best pediatric doctor Bhubaneswar. Nonetheless, you have to give seeing a physician significant thought if you're worried about your child's health. Take a look at the benefits of seeing a doctor.
Benefits of Digitizing School Health Records EduHealth1
School Health Records are mandatory to keep the data of students during the school year. So Using paper documents for recording data is quite difficult. So electronic health records are used for this purpose.
Read More: https://www.eduhealthsystem.com/electronic-health-record-software-for-school/
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
From Birth to Adolescence_ The Journey with Your Pediatrician.pptxAnkura Hospital
A new mother is faced with the dilemma of whether to take her child to visit a family doctor or the best pediatric doctor Bhubaneswar. Nonetheless, you have to give seeing a physician significant thought if you're worried about your child's health. Take a look at the benefits of seeing a doctor.
Benefits of Digitizing School Health Records EduHealth1
School Health Records are mandatory to keep the data of students during the school year. So Using paper documents for recording data is quite difficult. So electronic health records are used for this purpose.
Read More: https://www.eduhealthsystem.com/electronic-health-record-software-for-school/
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Patient Information Leaflet
1. Chief investigator: Prof. Michael Levin
Principal Investigator: Dr Marieke Emonts
Search Participant information sheet – parents & guardians
Introduction
We are inviting you as a parent or guardian to take part in a research study. The study will involve
you completing a short online survey identifying and estimating the personal non-medical costs
of your child’s admission to the family. Before you decide whether to take part, it is important
for you to understand why the research is being done and what it will involve. This information
sheet is for you to keep. Please take your time to read this information sheet and ask us questions
if anything is not clear, or if you would like more information. You should only take part in this
research study if you want to. Your decision will not affect your child’s clinical care.
Why is this research study needed?
Large numbers of children are admitted to hospital everyday with infections. The cost of these
admission to the hospital has been well defined and researched. However, little is known about
the non-medical personal out of pocket costs, such as food, fuel, and time taken off work, faced
by families and carers. This topic is an important issue as families are facing rising costs of living.
What is the aim of the research?
We want to estimate the non-medical out-of-pocket costs for families during a child’s admission.
The results may be used to help identify ways that we could help reduce the financial burden
related to an admission.
Why have my child and I been chosen?
You and your child have been chosen as he/she may have an infectious or an inflammatory illness
that has required an admission to hospital.
What are the advantages and disadvantages to joining the study?
The study may not help you directly, but the findings of the study could help improve services in
the future for children and their carers.
What will happen if you wish to withdraw your child from the study?
You may withdraw from the study at any time, you don’t have to give a reason and it will not
affect the standard of care your child receives.
Understanding and describing the non-medical out
of pocket cost of a hospital admission to families
and guardians
2. What will happen to the results of the research study?
The study will take 6 months to complete. Findings will be shared with people who organise
health care services. Results of this research may be published in scientific journals. Details of
this will be posted on the project website (www.diamonds2020.eu) and on twitter
(@DIAMONDS_2020). You or your child will not be identified in any information written or
presented about the study.
Who is organising and funding the research?
The research is being co-ordinated by Professor Michael Levin in the Section of Paediatric
Infectious Disease at Imperial College London in collaboration with hospitals and scientific
institutions in and outside Europe. This study has been reviewed and given approval by the
Dulwich Research Ethics Committee. The research is funded by the European Commission.
What are the contact details for the local research team?
The Principal Investigator at The Newcastle upon Tyne Hospitals NHS Foundation Trust is Marieke
Emonts can be contacted at 0191 2825984. The local research team at The Newcastle upon Tyne
Hospitals NHS Foundation Trust can be contacted at 0191 2820553.
Which data will the NHS hospital Trust share with Imperial College?
The only personal information to be shared with Imperial College will be your child’s date of
birth. Imperial College has a secure cloud-based Research Data Storage system which complies
with GDPR. Imperial College will ensure that this personal information is kept secure, and it will
never be published.
Who is responsible for looking after the data?
Imperial College London is the sponsor for this study and will act as the data controller. This
means that Imperial College London is responsible for looking after your results. All information
collected will be kept confidential and non-identifiable.
What if there is a problem?
If you wish to complain or have any concerns about any aspect of the way you or your child has
been treated during the course of this study then you should immediately inform the Principal
Investigator: Marieke Emonts at 0191 2825984.
In addition, the Patient Advice and Liaison Service (PALS) offers confidential advice, support and
information for health-related matters. They can also give you advice on the NHS complaints
procedure and how to get independent help if you want to make a complaint. You can find your
nearest PALS office on the NHS Choices website or from your GP surgery, hospital or phone NHS
111. If you are still not satisfied with the response, you may contact the Research Governance
and Integrity Team (RGIT) at Imperial College. If you incur costs as a result of a complaint, you
may have to pay your own costs.
How can you complain about use of your personal data?
3. If you wish to raise a complaint on how we have handled your personal data, please contact
Imperial College London’s Data Protection Officer via email at dpo@imperial.ac.uk, via telephone
on 020 7594 3502 and/or via post at Imperial College London, Data Protection Officer, Faculty
Building Level 4, London SW7 2AZ.
If you are not satisfied with our response or believe we are processing your child’s personal data
in a way that is not lawful you can complain to the Information Commissioner’s Office (ICO)
(www.ico.org.uk or 0303 123 1113). The ICO does recommend that you seek to resolve matters
with the data controller (us) first before involving the regulator.
Thank you for reading about our study
4. Chief investigator: Prof. Michael Levin
Principal Investigator: Dr Marieke Emonts
Search Participant information sheet – Children aged 5-12 years
Introduction You and your parents/ carer are being invited to take part in a research
study. They will be asked to answer some questions online. You should only take part if
you want to. If you do not want to that is okay, and it will not affect your stay in hospital.
Why are we doing this research? We want to know what it is like for your familiy when you come
to stay with us. We want to know things like how you get here, where you get your food from
and who stays with you. We want to know if there is anything we can do to make the stay better.
Why have you been chosen? You have been asked because you have had to come into hospital
and stay overnight to get better.
What are the good points and bad points about joining the study? The study might not help
you, but the answers may help other children and their families when they come into hospital.
What will happen if I change my mind? If you do not want to be part of the study anymore that
is okay, you can leave at any time no questions asked!
What will happen to the results of the research study? We hope to write up the results and
present them to other people who want to know more about what it is like for families/carers to
stay in hospital.
What if there is a problem? If you are unhappy during the study, then you should tell us or your
parents.
Who to contact for further information - The Principal Investigator at The Newcastle
upon Tyne Hospitals NHS Foundation Trust is Marieke Emonts can be contacted at 0191
2825984. The local research team at The Newcastle upon Tyne Hospitals NHS
Foundation Trust can be contacted at 0191 2820553.
Thank you for reading about our study
Understanding and describing the non-medical out
of pocket cost of hospital admission to families and
carers